Literature DB >> 19652917

The interaction between thymine DNA glycosylase and nuclear receptor coactivator 3 is required for the transcriptional activation of nuclear hormone receptors.

Shirley Chiang1, Tanya Burch, Gary Van Domselaar, Kevin Dick, Alina Radziwon, Craig Brusnyk, Megan Rae Edwards, Jessica Piper, Todd Cutts, Jingxin Cao, Xuguang Li, Runtao He.   

Abstract

The T:G mismatch specific DNA glycosylase (TDG) is known as an important enzyme in repairing damaged DNA. Recent studies also showed that TDG interacts with a p160 protein, steroid receptor coactivator 1 or nuclear receptor coactivator 1 (SRC1), and is involved in transcriptional activation of the estrogen receptor. However, whether other members of the p160 family are also involved in TDG-interaction and signal transduction regulation remains to be seen. In this study, we employed the mammalian two-hybrid system to investigate the interaction between TDG and another member of the p160 family, nuclear receptor coactivator 3 (NCoA-3). We found that a DXXD motif from aa 294-297 within TDG was responsible for the TDG-NCoA-3 interaction, we also found that a LLXXXL motif (X means any amino acid) from aa 1029-1037 (LLRNSL) and a merged LLXXL motif (LLDQLHTLL) from aa 1053-1061 in NCoA-3 were important for the TDG-NCoA-3 interactions. Mutation of the two aspartic acids (aa 294 and 297) into two alanines in TDG significantly affected the interaction and subsequent transcriptional activation of several steroid hormone receptors including, estrogen-, androgen- and progesterone- receptors in Huh7 cells. We also identified that mutations of NCoA-3 at either leucines 1029-1030 or 1053-1054 (replaced by alanines) also reduced the interaction activity between TDG and NCoA1. These data indicated that the TDG-NCoA-3 interaction is important for broad range activation of steroid hormone nuclear receptors, and may also contribute significantly to further understanding of TDG-related nuclear receptor regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19652917     DOI: 10.1007/s11010-009-0223-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  VADAR: a web server for quantitative evaluation of protein structure quality.

Authors:  Leigh Willard; Anuj Ranjan; Haiyan Zhang; Hassan Monzavi; Robert F Boyko; Brian D Sykes; David S Wishart
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

Review 3.  The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators.

Authors:  Michael R Stallcup; Jeong Hoon Kim; Catherine Teyssier; Young-Ho Lee; Han Ma; Dagang Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

4.  Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3.

Authors:  Paola Mussi; Chundong Yu; Bert W O'Malley; Jianming Xu
Journal:  Mol Endocrinol       Date:  2006-08-17

5.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

6.  Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53.

Authors:  S K Lee; H J Kim; J W Kim; J W Lee
Journal:  Mol Endocrinol       Date:  1999-11

Review 7.  Estrogen receptor interaction with estrogen response elements.

Authors:  C M Klinge
Journal:  Nucleic Acids Res       Date:  2001-07-15       Impact factor: 16.971

8.  Expression of T:G mismatch-specific thymidine-DNA glycosylase and DNA methyl transferase genes during development and tumorigenesis.

Authors:  K Niederreither; M Harbers; P Chambon; P Dollé
Journal:  Oncogene       Date:  1998-09-24       Impact factor: 9.867

9.  Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs.

Authors:  X Dong; J R G Challis; S J Lye
Journal:  J Mol Endocrinol       Date:  2004-06       Impact factor: 5.098

10.  T:G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motif.

Authors:  Marie J Lucey; Dongsheng Chen; Jorge Lopez-Garcia; Stephen M Hart; Fladia Phoenix; Rajai Al-Jehani; John P Alao; Roger White; Karin B Kindle; Régine Losson; Pierre Chambon; Malcolm G Parker; Primo Schär; David M Heery; Lakjaya Buluwela; Simak Ali
Journal:  Nucleic Acids Res       Date:  2005-11-10       Impact factor: 16.971

View more
  5 in total

Review 1.  Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis.

Authors:  Xuehe Xu; David S Watt; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-14       Impact factor: 3.848

Review 2.  Active DNA demethylation in plants and animals.

Authors:  H Zhang; J-K Zhu
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-11-28

Review 3.  The current state of eukaryotic DNA base damage and repair.

Authors:  Nicholas C Bauer; Anita H Corbett; Paul W Doetsch
Journal:  Nucleic Acids Res       Date:  2015-10-30       Impact factor: 16.971

Review 4.  The Role of Thymine DNA Glycosylase in Transcription, Active DNA Demethylation, and Cancer.

Authors:  Oladapo Onabote; Haider M Hassan; Majdina Isovic; Joseph Torchia
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

5.  Hormone stimulation of androgen receptor mediates dynamic changes in DNA methylation patterns at regulatory elements.

Authors:  Vineet K Dhiman; Kristopher Attwood; Moray J Campbell; Dominic J Smiraglia
Journal:  Oncotarget       Date:  2015-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.